Ensysce Biosciences Future Growth
Future criteria checks 5/6
Ensysce Biosciences is forecast to grow earnings and revenue by 102.6% and 124% per annum respectively while EPS is expected to grow by 109.9% per annum.
Key information
102.6%
Earnings growth rate
109.9%
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | 124.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 14 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 47 | 28 | N/A | N/A | 2 |
| 12/31/2025 | N/A | -13 | N/A | N/A | 2 |
| 12/31/2024 | 4 | -8 | N/A | N/A | 2 |
| 9/30/2024 | 4 | -8 | -9 | -9 | N/A |
| 6/30/2024 | 1 | -11 | -10 | -10 | N/A |
| 3/31/2024 | 2 | -12 | -11 | -11 | N/A |
| 12/31/2023 | 2 | -11 | -11 | -11 | N/A |
| 9/30/2023 | 3 | -13 | -12 | -12 | N/A |
| 6/30/2023 | 3 | -20 | -17 | -17 | N/A |
| 3/31/2023 | 3 | -26 | -18 | -18 | N/A |
| 12/31/2022 | 3 | -25 | -18 | -18 | N/A |
| 9/30/2022 | 3 | -30 | -18 | -18 | N/A |
| 6/30/2022 | 4 | -38 | -15 | -15 | N/A |
| 3/31/2022 | 4 | -31 | -11 | -11 | N/A |
| 12/31/2021 | 4 | -30 | -8 | -8 | N/A |
| 9/30/2021 | 2 | -19 | -5 | -5 | N/A |
| 6/30/2021 | 2 | 0 | -1 | -1 | N/A |
| 3/31/2021 | 3 | 0 | -1 | -1 | N/A |
| 12/31/2020 | 4 | 0 | -1 | -1 | N/A |
| 12/31/2019 | 2 | -10 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ENSC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: ENSC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ENSC is expected to become profitable in the next 3 years.
Revenue vs Market: ENSC's revenue (124% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: ENSC's revenue (124% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ENSC's Return on Equity is forecast to be high in 3 years time